Fig. 2.
Barriers to drug repurposing and future directions This figure lists the current barriers to a successful drug repurposing and repositioning including patent, regulatory and organizational hurdles and summarizes future directions and recommendations (modified from Pushpakom et al. Nature Reviews 2018). EU, European Union; US, United States; R&D, Research and Development; NIH-NCATS, National Institute of Health – National Center for Advancing translational Sciences; MRC, Medical Research Council; SPARK, Translational Research Program of Stanford.